Novo Nordisk, Pfizer sweeten bid for Metsera
Digest more
Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues ...
(Reuters) -Eli Lilly and Novo Nordisk plan to announce new drug pricing deals with the White House, including for their ...
Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...
A deal with Lilly and Novo would be significant for the administration’s push for lower drug prices for Americans.
Eli Lilly and Company (NYSE:LLY) shares are trading slightly lower on Tuesday after its previous gains following reports ...
This article first appeared on GuruFocus. Novo Nordisk AS (OCSE:NOVO B) is set to release its Q3 2025 earnings on Nov 5, 2025 ...
Novo Holdings, which controls obesity drugmaker Novo Nordisk, is sharpening its focus on India, targeting single-specialty ...
Pfizer et Novo Nordisk se livrent une guerre de milliards pour se positionner sur le marché florissant des médicaments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback